39.75 USD
-0.91 (-2.24%)
39.88 USD
+0.13 (+0.33%)
ChartMill assigns a Buy % Consensus number of 71% to NUVA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 50.72. This target is 27.6% above the current price.
- NUVA was analyzed by 22 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about NUVA.
- In the previous month the buy percentage consensus was at a similar level.
- NUVA was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-04 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-19 | Truist Securities | Maintains | Hold -> Hold |
| 2023-05-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-12 | Barclays | Maintains | Overweight -> Overweight |
| 2023-05-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-02-23 | JP Morgan | Maintains | Neutral |
| 2023-02-23 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-02-10 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-02-10 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-02-10 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-02-09 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-01-31 | Truist Securities | Maintains | Buy |
| 2023-01-06 | Needham | Downgrade | Buy -> Hold |
| 2022-11-10 | Needham | Maintains | Buy |
| 2022-11-10 | RBC Capital | Maintains | Outperform |
| 2022-11-10 | Wells Fargo | Maintains | Overweight |
| 2022-11-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-10 | Piper Sandler | Maintains | Overweight |
| 2022-10-18 | Barclays | Initiate | Overweight |
| 2022-10-12 | Jefferies | Initiate | Hold |
| 2022-10-07 | Truist Securities | Maintains | Buy |
| 2022-10-07 | Baird | Maintains | Neutral |
| 2022-10-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-30 | Needham | Maintains | Buy |
| 2022-08-04 | Piper Sandler | Maintains | Overweight |
| 2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-06 | Morgan Stanley | Maintains | Equal-Weight |
NUVASIVE INC / NUVA FAQ
What is the price target for NUVA stock?
22 analysts have analysed NUVA and the average price target is 50.72 USD. This implies a price increase of 27.6% is expected in the next year compared to the current price of 39.75.
Can you provide the consensus rating for NUVASIVE INC stock?
The consensus rating for NUVASIVE INC (NUVA) is 70.9091 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NUVASIVE INC (NUVA) stock?
The number of analysts covering NUVASIVE INC (NUVA) is 22.